ATE212T1 - Intrarespiratorischer impfstoff, darin verwendeter modifizierter bakteriumstamm, dosierungsform des impfstoffes und verfahren zu seiner herstellung. - Google Patents

Intrarespiratorischer impfstoff, darin verwendeter modifizierter bakteriumstamm, dosierungsform des impfstoffes und verfahren zu seiner herstellung.

Info

Publication number
ATE212T1
ATE212T1 AT79810169T AT79810169T ATE212T1 AT E212 T1 ATE212 T1 AT E212T1 AT 79810169 T AT79810169 T AT 79810169T AT 79810169 T AT79810169 T AT 79810169T AT E212 T1 ATE212 T1 AT E212T1
Authority
AT
Austria
Prior art keywords
vaccine
intrarespiratory
production
dosage form
bacterial strain
Prior art date
Application number
AT79810169T
Other languages
English (en)
Inventor
William Paul Switzer
Daniel Owen Farrington
Robert Allen Goodnow
Floyd Jerry Shade
Thomas Anthony Sloboth
Original Assignee
Iowa State University Research Foundation, Inc.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/967,477 external-priority patent/US4225583A/en
Application filed by Iowa State University Research Foundation, Inc., filed Critical Iowa State University Research Foundation, Inc.,
Priority claimed from EP79810169A external-priority patent/EP0012718B1/de
Application granted granted Critical
Publication of ATE212T1 publication Critical patent/ATE212T1/de

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT79810169T 1978-12-07 1979-11-30 Intrarespiratorischer impfstoff, darin verwendeter modifizierter bakteriumstamm, dosierungsform des impfstoffes und verfahren zu seiner herstellung. ATE212T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96747878A 1978-12-07 1978-12-07
US05/967,477 US4225583A (en) 1978-12-07 1978-12-07 Intra-respiratory vaccine for prevention of Bordetella bronchiseptica infection and method of use
EP79810169A EP0012718B1 (de) 1978-12-07 1979-11-30 Intrarespiratorischer Impfstoff, darin verwendeter modifizierter Bakteriumstamm, Dosierungsform des Impfstoffes und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
ATE212T1 true ATE212T1 (de) 1981-10-15

Family

ID=27224630

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79810169T ATE212T1 (de) 1978-12-07 1979-11-30 Intrarespiratorischer impfstoff, darin verwendeter modifizierter bakteriumstamm, dosierungsform des impfstoffes und verfahren zu seiner herstellung.

Country Status (2)

Country Link
AT (1) ATE212T1 (de)
ES (2) ES486579A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0122036A1 (de) * 1983-03-09 1984-10-17 Teijin Limited Puderförmige pharmazeutische Zusammensetzung zur nasalen Anwendung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0122036A1 (de) * 1983-03-09 1984-10-17 Teijin Limited Puderförmige pharmazeutische Zusammensetzung zur nasalen Anwendung

Also Published As

Publication number Publication date
ES486579A1 (es) 1980-10-01
ES8101890A1 (es) 1980-12-16
ES487816A0 (es) 1980-12-16

Similar Documents

Publication Publication Date Title
SE7708845L (sv) Framstellning av d(-)-3-hydroxismorsyra
ES8600401A1 (es) Un procedimiento para la preparacion de nuevos derivados de furanona (sustancia fr 51785)
GB1522006A (en) Feline calicivirus vaccine and a process for the production thereof
US2917435A (en) Preparation of 2-keto-1-gulonic acid by pseudomonas aeruginosa
SE8301406L (sv) Immobiliserad mikroorganism
ATE212T1 (de) Intrarespiratorischer impfstoff, darin verwendeter modifizierter bakteriumstamm, dosierungsform des impfstoffes und verfahren zu seiner herstellung.
ES444311A1 (es) Un procedimiento de lisis del residuo micelar obtenido en laproduccion de antibioticos.
ES8106176A1 (es) Un metodo de produccion de un extracto soluble en agua de corincbacterias aerobias no patogenas.
GB978593A (en) Method for producing l-homoserine by fermentation
ATE18135T1 (de) Verfahren zur herstellung von einem verbessertem mutantenstamm von bordetella bronchiseptica und diesen enthaltendes lebendes attenuiertes vakzin.
SE7607909L (sv) Forfarande for framstellning av bioproteiner med hjelp av mikroorganismer samt mikroorganismer for detta endamal
GB1394849A (en) 5-dihydrocoriolin c and process for producing the same
SE8007818L (sv) Glukos-6-fosfatdehydrogenas och forfarande for framstellning derav
ES313427A1 (es) Un metodo para la preparacion de una vacuna de brucella abortus viviente.
DE3484989D1 (de) Unikale, monogenetische streptokinase, ihre herstellung und verwendung.
BG40658A3 (en) Method for preparing glucoisomerase enzyme
Griffith et al. Nicotine Oxidation by Arthrobacter
JPS56121497A (en) Preparation of polysaccharide
JPS5369882A (en) Preparation of l-isoleucine
ATE18256T1 (de) Antianaemische zusammensetzung und verfahren zu deren herstellung.
IE35437B1 (en) Improvements in or relating to methods of preparation and use of a vaccine from bacteroides nodosus
ES465744A3 (es) Un procedimiento para preparar un insecticida microbiano.
GB901433A (en) Pulpy kidney disease/tetanus/lamb dysentery vaccine
JPS5526874A (en) Production of l-serine through fermentation process
GB976093A (en) Method for producing l-homoserine by fermentation process

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee